Wenger Vieli advised institutional staking infrastructure provider Chorus One, and its shareholders, on all Swiss legal and tax aspects of the company’s sale to Bitwise Asset Management. Pursuant to the deal, Chorus One joins
Kellerhals Carrard advised Seprify on a CHF 12.25 million series A financing round. Headquartered in Marly, Seprify engineers cellulose at the micro- and nano-scale to create materials capable of replacing titanium dioxide (TiO₂). Una Terra Early
Advestra advised Sandoz, a generic and biosimilar medicines specialist with headquarters in Basel, on its CHF 550 million bonds issuance. The issuance comprises a CHF 275 million tranche with a six-year maturity and a 1.1875% coupon, and a
On March 10, 2026, Sunshine SwissCo, a consortium led by EQT, the Abu Dhabi Investment Authority (ADIA), and Auba Investment, officialised the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors
Holman Fenwick Willan (HFW) opened an aviation practice in Geneva under the leadership of newly hired partner Laurent Chassot (pictured), joining from Gbf together with senior associate Yolande Lagrange and special counsel Christophe Platel. The
Roche Holding, Roche Holdings, and Roche Finanz entered into a Swiss law governed USD 7.5 bn revolving credit facility agreement arranged by and syndicated among twelve international banks, coordinated by Deutsche Bank. In connection with the
Advestra advised Swiss Prime Site as the Swiss real estate company placed green convertible bonds in the total aggregate amount of CHF 350 million. The net proceeds from the issuance are expected to be used
Walder Wyss advised Xsensio, as the Swiss deep-tech company closed a USD 7 million series A financing round. San Francisco-based venture capital firm WI Harper led the round, with participation from Privilège Ventures, the European
Nexus Avocats advised Clee Medical, a Swiss neurotech startup with headquarters in Geneva, throughout its seed financing round. The round was led by HTGF High-Tech Gründerfonds, with participation from Zürcher Kantonalbank, Kickfund, FONGIT
Lonza entered into a definitive agreement for the sale of the Capsules & Health Ingredients (CHI) business to Lone Star Funds, at an enterprise value of CHF 2.3 billion (USD 3 billion). In connection with the deal
